Literature DB >> 16203808

Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer.

Robert Ivkov1, Sally J DeNardo, Wolfgang Daum, Allan R Foreman, Robert C Goldstein, Valentin S Nemkov, Gerald L DeNardo.   

Abstract

OBJECTIVE: Magnetic nanoparticles conjugated to a monoclonal antibody can be i.v. injected to target cancer tissue and will rapidly heat when activated by an external alternating magnetic field (AMF). The result is necrosis of the microenvironment provided the concentration of particles and AMF amplitude are sufficient. High-amplitude AMF causes nonspecific heating in tissues through induced eddy currents, which must be minimized. In this study, application of high-amplitude, confined, pulsed AMF to a mouse model is explored with the goal to provide data for a concomitant efficacy study of heating i.v. injected magnetic nanoparticles.
METHODS: Thirty-seven female BALB/c athymic nude mice (5-8 weeks) were exposed to an AMF with frequency of 153 kHz, and amplitude (400-1,300 Oe), duration (1-20 minutes), duty (15-100%), and pulse ON time (2-1,200 seconds). Mice were placed in a water-cooled four-turn helical induction coil. Two additional mice, used as controls, were placed in the coil but received no AMF exposure. Tissue and core temperatures as the response were measured in situ and recorded at 1-second intervals.
RESULTS: No adverse effects were observed for AMF amplitudes of < or = 700 Oe, even at continuous power application (100% duty) for up to 20 minutes. Mice exposed to AMF amplitudes in excess of 950 Oe experienced morbidity and injury when the duty exceeded 50%.
CONCLUSION: High-amplitude AMF (up to 1,300 Oe) was well tolerated provided the duty was adjusted to dissipate heat. Results presented suggest that further tissue temperature regulation can be achieved with suitable variations of pulse width for a given amplitude and duty combination. These results suggest that it is possible to apply high-amplitude AMF (> 500 Oe) with pulsing for a time sufficient to treat cancer tissue in which magnetic nanoparticles have been embedded.

Entities:  

Mesh:

Year:  2005        PMID: 16203808     DOI: 10.1158/1078-0432.CCR-1004-0016

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  61 in total

Review 1.  Treating metastatic cancer with nanotechnology.

Authors:  Avi Schroeder; Daniel A Heller; Monte M Winslow; James E Dahlman; George W Pratt; Robert Langer; Tyler Jacks; Daniel G Anderson
Journal:  Nat Rev Cancer       Date:  2011-12-23       Impact factor: 60.716

Review 2.  Update: Turning the heat on cancer.

Authors:  Gerald L DeNardo; Sally J DeNardo
Journal:  Cancer Biother Radiopharm       Date:  2008-12       Impact factor: 3.099

3.  Magnetic nanoparticle temperature estimation.

Authors:  John B Weaver; Adam M Rauwerdink; Eric W Hansen
Journal:  Med Phys       Date:  2009-05       Impact factor: 4.071

4.  Tailored magnetic nanoparticles for optimizing magnetic fluid hyperthermia.

Authors:  Amit P Khandhar; R Matthew Ferguson; Julian A Simon; Kannan M Krishnan
Journal:  J Biomed Mater Res A       Date:  2011-12-30       Impact factor: 4.396

5.  Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release.

Authors:  Baeckkyoung Sung; Steven Shaffer; Michal Sittek; Talib Alboslemy; Chanjoong Kim; Min-Ho Kim
Journal:  J Vis Exp       Date:  2016-02-13       Impact factor: 1.355

6.  Iron Oxide Hyperthermia And Radiation Cancer Treatment.

Authors:  Sm Cassim; Aj Giustini; Aa Petryk; Ra Strawbridge; Pj Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-23

7.  Assessment of intratumor non-antibody directed iron oxide nanoparticle hyperthermia cancer therapy and antibody directed IONP uptake in murine and human cells.

Authors:  Pj Hoopes; Ja Tate; Ja Ogden; Rr Strawbridge; Sn Fiering; Aa Petryk; Sm Cassim; Aj Giustini; E Demidenko; R Ivkov; S Barry; P Chinn; A Foreman
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-23

8.  Magnetic resonance imaging contrast of iron oxide nanoparticles developed for hyperthermia is dominated by iron content.

Authors:  Michele Wabler; Wenlian Zhu; Mohammad Hedayati; Anilchandra Attaluri; Haoming Zhou; Jana Mihalic; Alison Geyh; Theodore L DeWeese; Robert Ivkov; Dmitri Artemov
Journal:  Int J Hyperthermia       Date:  2014-05       Impact factor: 3.914

Review 9.  Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics.

Authors:  Elly De Vlieghere; Laurine Verset; Pieter Demetter; Marc Bracke; Olivier De Wever
Journal:  Virchows Arch       Date:  2015-08-11       Impact factor: 4.064

Review 10.  Towards a single-chip, implantable RFID system: is a single-cell radio possible?

Authors:  Peter Burke; Christopher Rutherglen
Journal:  Biomed Microdevices       Date:  2010-08       Impact factor: 2.838

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.